Prior reports from this laboratory have described the experimental basis for our understanding of the rosy locus (ry: 3-520) of Drosophila melanogaster as a bipartite genetic entity consisting of a structural element that codes for the xanthine dehydrogenase (XDH) peptide and a contiguous cw-acting control element immediately to the left of the structural element. Although the left end (5') of the structural element has been well denned, the right boundary (3') has been given only casual treatment in our prior reports. In our recent studies of rosy locus expression we have been concerned with the production and identification of mutations in the non-structural regions immediately flanking the structural element. An improved definition of the right end of the structural element is essential to this analysis. In addition to producing a better definition of the right boundary of the structural element, this study produced several phenotypically novel mutations. These mutations were classified initially ascontrolelementmutations, but uponanalysis were found to map within the rosy structural element. No evidence was obtained for the existence of a control element contiguous with the right end of the structural element.
Introduction
The rosy locus of Drosophila melanogaster is essential for xanthine dehydrogenase (XDH) activity and is located on the right arm of chromosome three at map position 520. The immediate genetic region surrounding rosy is well defined and the locus is an independent genetic unit within that region . The locus was originally defined by brown eye colour mutants which were deficient in drosopterin pigment. Such mutants were subsequently shown to exhibit no detectable xanthine dehydrogenase (XDH) activity (Glassman & Mitchell, 1959) . Two lines of evidence establish the rosy locus as the structural gene for XDH: (1) XDH activity increases with increasing * Present address: Department of Molecular Biology and Genetics, University of Guelph, Guelph, Ontario, Canada NiG 2W1
doses of ry + alleles in diploid flies (Grell, 1962; Glassman, Karam & Keller, 1962) and (2) variation in electrophoretic mobility was shown to map to the vicinity of the rosy locus (Yen & Glassman, 1965) , and, subsequently, to map within the rosy locus as defined by ry null mutants Gelbart et al. 1974) .
Extensive fine structure analysis of rosy eye colour variants provided a linear array of sites associated with loss of XDH activity (Chovnick, Ballantyne & Holm, 1971) . More recent experiments with a variety of unambiguous structural mutations have defined the genetic limits of the structural gene Gelbart et al. 1974; .
There is, however, an ambiguity in the genetic definition of one of the boundaries of the XDH structural element. Essentially, the outer boundaries of the structural element are defined by intragenic fine structure mapping experiments that located the relative map positions of sites associated with unambiguous XDH peptide alterations. The left boundary of the structural element, defined by the complementing rosy eye colour mutant ry 606 , has not changed despite extensive testing in recent years. In contrast, the right boundary has been given only casual treatment in our prior reports (loc. cit.) which provided evidence for the rightmost sites being ry 41 , ry elH and ry 2 . Of these sites, only the electrophoretic site, ry e111 , is an unambiguous site of structural variation. The mutant ry 2 was listed as an allele exhibiting interallelic complementation on the basis of a slight eye colour complementation seen in one mutant heteroallele combination. However, we are unable to confirm this diagnosis in terms of XDH activity. Moreover, recent association of this spontaneous mutant with a large insertion (W. Bender, Personal communication) further confounds this classification.
As part of our goal to explore the control of rosy locus expression, we have been concerned with the production and identification of mutations in the nonstructural regions immediately flanking the structural element. An essential feature of such an analysis Chovnick et al. (1976) , Hilliker et al. (1980) , and Hilliker & Chovnick (1981 involves an improved definition of the right end of the structural element. This task assumes particular importance since Cote et al. (1986) , utilizing strand specific M13 probes, have demonstrated that the rosy RNA is transcribed from left to right (5' to 3') on the genetic map (Figs. 2 and 3 ). The present studies produced several novel and unanticipated classes of mutations. One class, involving heterochromatic position effects on rosy locus expression, is discussed elsewhere Rushlow, Bender & Chovnick, 1984) . The present report describes several additional mutations, each representing a phenotypic class whose initial biochemical characterization led to its designation as a putative, cw-acting control mutant.
However, upon further study, each was found to be a rosy locus structural element mutation of a class heretofore unseen in this system.
Materials and Methods
(i) The genetic system Fig. 1 presents a genetic map of the centromere proximal region of chromosome 3 noting the rosy region and closely linked gene markers used in this investigation.
Rosy locus variants have been the subject of an intensive and continuing intragenic mapping analysis. Fig. 2 summarizes the state of this effort prior to the present report. Fig. 2 44-5 15 6 13 9 551 10-9 132-8 non-complementing, rosy eye colour mutant sites. Estimation of the boundaries of the XDH coding element is provided by the maps of three classes of unambiguous coding element site variants presented in Fig. 2B (XDH~, allele-complementing, rosy eye colour mutant sites), Fig. 2C (electrophoretic mobility sites) and Fig. 2D (purine sensitive 'leaky' structural mutant sites). Additionally, experiments from this laboratory have elaborated a cw-acting control element which maps between the left, centromere proximal boundary of the XDH structural element and the immediately adjacent vital gene, 1{3)S12 (Fig. 3) . The control element is denned by two recombinationally separable site variants. Thus, the ry i409H variant is associated with a tissue specific increase in rosy locus expression in contrast to the normal, ry i40BN , and ry il005L is associated with a non-tissue specific reduction in expression in contrast to the normal, r y il005N (Clark et al. 1984) .
(ii) Genetic fine structure analysis Large scale fine structure recombination tests were carried out making use of the purine selective system described in McCarron et al. (1979) .
(iii) Mutants used in the analysis
The allele-complementing rosy eye colour mutation, ry Ll9 , is an ethyl methanesulphonate (EMS) induced mutation provided by E. B. Lewis. The purine sensitive, 'leaky' mutations ryv* 218 , ryv* 223 and ry^8 228 are derived from the ry +2 allele while ry ps612 is derived from the ry +e allele. These resulted from EMS mutagenesis experiments described earlier . The ry** S20S mutation resulted from a 1-ethyl-1-nitrosouracil (ENU) mutagenesis of the ry +s allele (McCarron & Chovnick, 1981) .
(iv) XDH tests
Electrophoresis procedures are those of McCarron et al. (1979) , modified only in that the gel is 6% acrylamide and 0-3% Af,W-inethylenebisacrylamide. Enzyme activity is measured by the fluorometric procedure described by Chovnick et al. (1970) as modified in McCarron et al. (1979) . The rocket immunoelectrophoresis procedure is described by McCarron et al. (1979) .
Results
A number of purine sensitive, 'leaky' mutant alleles of the rosy locus were characterized with respect to XDH CRM (cross-reacting material) and XDH enzyme activity in extracts of mutant homozygotes relative to extracts of their respective parental wild-type isoallele homozygotes. Those purine sensitive mutations associations with normal CRM levels and reduced enzyme activity were assigned as structural element variants. However, several additional classes of mutants, associated with both altered CRM and enzyme activity were subjected to further analysis as putative control element variants. The XDH activity and CRM levels associated with representative members of these classes of variants is presented in Table 1 . Further genetic and biochemical analyses of these variants is discussed below.
Enzyme assays of extracts of homozygous ryf s223 adults indicated an approximate 50% decrease in XDH activity, and this was clearly correlated with reduced amounts of XDH CRM (Table 1) . We were led by these observations to consider ry ps 223 as a putative control variant subject to fine structure mapping studies to determine its location within the rosy locus. Table 2 summarizes results of those mapping studies. The presentation in this and subsequent tables follows a classification of recombinants as crossovers or conversions based upon flanking markers (reviewed in Hilliker & Chovnick, 1981) . The phenotypic classification of recombinants with respect to electrophoretic mobility relates to unselected electrophoretic site heterozygosity (Fig. 2C) . The classification is consistent with prior reports from this laboratory and is discussed at length by Gelbert, . The crossover class of recombinants in the first experiment (Table 2 ) establishes the position of ry ps 223 to the right of ry 606 and hence to the right of the previously described control element (Fig. 3) . Prior study established the existence and location of an electrophoretic site difference (e217) between the parental wild-type alleles that is responsible for their XDH mobility difference Table 2 ) exhibited an electrophoretic mobility of 1 05 (e217F, ell IF), we are able to place ps223 to the right of 106. However, these data are ambiguous with respect to the placement of ps223 relative to the elll site. Since one of the four conversions of ps223 exhibited a co-conversion for the elll site, we conclude that these sites are in close proximity to each other. The failure to recover crossovers in the large scale recombination experiment between r y ps223 and ry 41 (Expt. 3 of Table 2 ) implies a close proximity of these mutations. Since the ry 41 allele is associated with a very high conversion frequency (Chovnick, Ballantyne & Holm, 1971; Hilliker & Chovnick, 1981) , the apparent absence of ry 41 conversions in this experiment provides additional evidence for the immediate proximity of ry
VS 223
On the basis of its complementation with ry 4O6 a.n& its map position to the right of ry 41 , the ry 2 allele is considered to be the rightmost known structural variant. Consequently, we assayed for recombination between r yvs 223 a n ( j r j;2 a n ( j f a ii e( j t o observe crossovers in a very large scale experiment (Expt. 4, Table 2 ).
At this point in the study, it appeared that ry ps 223 was a mutation within a control element region located at the right end of the structural element of the rosy locus, and thus identified a new control element region for this gene.
However (Table 1) . Prior fine structure mapping had positioned ry ps612 to the right of ry 8 . Recombination was assayed between ry ps612 and ry 41 , and the results definitely place ry ps e12 within the XDH structural element. We infer that the ry ps 612 lesion produces a protein with a much reduced catalytic ability. Its excess accumulation suggests several alternative models discussed below (see Discussion).
(iv) The right end of the XDH structural element
As noted above (see Introduction), ry 2 is not entirely suitable as a marker for the right end of the structural element. It is associated with reduced crossing over in its vicinity, and exhibits an exceedingly low conversion frequency (Chovnick, Ballantyne & Holm, 1971) . Indeed, it has recently been shown to be associated with a large insertion of extraneous DNA at the right end of the locus (W. Bender in Hilliker & Chovnick, 1981) which may severely limit the recovery of intragenic recombinants in its vicinity.
At this juncture, it became apparent that mutants were available to permit further experimental definition of the right end of the XDH structural element. Moreover, such effort is essential for the eventual analysis of non-coding variants at this end of the locus. Several known structural variants (rosy complementing alleles and purine sensitive structural variants) were mapped against ry 41 (a defined right end null mutation) in an effort to extend and further define the right structural terminus of the rosy locus. The ry L1B allele proved to be a useful right end marker. Unlike ry 2 , ry L1 *is an excellent complementing allele of the locus restoring full wild-type eye colour and biochemically detectable XDH activity in several complementing heterozygotes with other ry complementing alleles , and recombination analysis indicated that ry L19 was to the right of ry 41 (Row 1, Table 5 ). The appearance of two electrophoretic mobility classes among the ry L19 conversions indicates the existence of an electrophoretic site heterozygosity to the right of ry 41 in the immediate vicinity of, but separable from, ry L19 . Thus, the ry L19 mutation, and an electrophoretic site in its immediate vicinity define the right end of the XDH structural element.
Several experiments were conducted to map the location of the structural element mutation ry ps 21S to the right end of the XDH structural element. Two experiments are summarized ( The ry ps520S allele and the experiments described below derive from studies carried out independent of those described in prior sections. Their inclusion in the present report relates to the identification of the right boundary of the XDH structural element. The ry ps5205 allele is associated with a borderline mutant eye colour, and very low XDH activity. Extracts do not stain for activity on routine polyacrylamide electrophoretic gels, but do stain faintly on immunoelectrophoretic gels. Table 6 ). Indeed, the crossoverdistanceobserved,00123mapunits,indicated that it lay near the extreme right end of the rosy locus. Accordingly, it was mapped against ry L19 , the right end structural boundary marker, and proved to be just to the right of ry L19 (Row 2, 
Discussion
Although the present study failed to discern control element function adjacent to the right end of the rosy locus structural element, we were successful in providing a genetic definition of the right end of the XDH structural element. Fig. 5 summarizes the current genetic map of the rosy locus.
Several mutations within the structural element exhibit unusual properties. Two alleles, ry vs223 and r yps228 w e r e initially considered as possible control variants on the basis of their biochemical and immunological characteristics (low XDH activity and correspondingly reduced levels of XDH CRM relative to their parental ry +2 isoallele). One of these mutations, ry p8223 , is clearly a structural variant. The low CRM level of mutant homozygotes, which led to its putative classification as an' underproducer', was due to the fact that the mutant lesion produces unstable homozygous XDH dimers. Examination of the XDH dimer array produced by the heterozygote involving ry vs223 and a very different wild-type electromorph (ry +13 ) provides opportunity toestimatetheavailablepeptidemonomers produced by the ry ps223 a\Me by virtue of the fact that they form stable hybrid dimers. We infer from the low level of CRM in ryP s223 homozygotes that XDH monomers must disappear rapidly unless' rescued' by dimer formation as in the hybrid dimer experiment. Perhaps monomeric forms of the peptide are subject to rapid proteolysis.
The basis of the biochemical phenotype associated with ry ps22S is unknown. It may produce an XDH peptide which is of low stability in both homozygous and hybrid dimers. The ryP sSJ2 allele is also unusual in that it exhibits lower XDH activity but elevated levels of XDH CRM. It may be a structural mutation that produces an XDH enzyme of lowered catalytic ability and greater molecular stability (or possibly altered affinity for XDH antibody).
An entirely different category of interpretation is raised by the recent discovery of a small intron within the previously defined structural region of the rosy locus (W. Bender and D. Curtis, Personal communication). These mutations might be lesions in a DNA sequence which may be important in RNA processing. Thus, a splice site lesion could explain the biochemical phenotype of ry ps22S , while ry pse12 may be a coding element lesion in the vicinity of an intron that enhances splicing.
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